| NDC Code | 0941-0464-01 |
|---|
| Package Description | 5000 mL in 1 BAG (0941-0464-01) |
|---|
| Product NDC | 0941-0464 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Dianeal For Peritoneal Dialysis |
|---|
| Non-Proprietary Name | Anhydrouse Dextrose, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride |
|---|
| Dosage Form | INJECTION, SOLUTION |
|---|
| Usage | INTRAPERITONEAL |
|---|
| Start Marketing Date | 20141027 |
|---|
| Marketing Category Name | UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE |
|---|
| Manufacturer | Baxter Healthcare Corporation |
|---|
| Substance Name | ANHYDROUS DEXTROSE; SODIUM CHLORIDE; SODIUM LACTATE; CALCIUM CHLORIDE; MAGNESIUM CHLORIDE |
|---|
| Strength | 13.6; 5.38; 4.48; .184; .051 |
|---|
| Strength Unit | g/1000mL; g/1000mL; g/1000mL; g/1000mL; g/1000mL |
|---|
| Pharmacy Classes | Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Blood Coagulation Factor [EPC],Increased Coagulation Factor Activity [PE],Calcium [CS],Cations, Divalent [CS],Calculi Dissolution Agent [EPC],Magnesium Ion Exchange Activity [MoA],Osmotic Laxative [EPC],Osmotic Activity [MoA],Inhibition Small Intestine Fluid/Electrolyte Absorption [PE],Increased Large Intestinal Motility [PE],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE] |
|---|